These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9484782)
1. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782 [TBL] [Abstract][Full Text] [Related]
2. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669 [TBL] [Abstract][Full Text] [Related]
3. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322 [TBL] [Abstract][Full Text] [Related]
4. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Takle LA; Knowles MA Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800 [TBL] [Abstract][Full Text] [Related]
5. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830 [TBL] [Abstract][Full Text] [Related]
7. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder]. Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150 [TBL] [Abstract][Full Text] [Related]
8. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer. Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532 [TBL] [Abstract][Full Text] [Related]
9. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516 [TBL] [Abstract][Full Text] [Related]
10. Allelotype of human bladder cancer. Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491 [TBL] [Abstract][Full Text] [Related]
11. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Knowles MA; Shaw ME; Proctor AJ Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582 [TBL] [Abstract][Full Text] [Related]
12. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas. Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624 [TBL] [Abstract][Full Text] [Related]
13. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858 [TBL] [Abstract][Full Text] [Related]
14. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185 [TBL] [Abstract][Full Text] [Related]
15. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485 [TBL] [Abstract][Full Text] [Related]
16. Clonal origin of lymph node metastases in bladder carcinoma. Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Noviello C; Courjal F; Theillet C Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339 [TBL] [Abstract][Full Text] [Related]
18. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb. Bell SM; Zuo J; Myers RM; Knowles MA Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728 [TBL] [Abstract][Full Text] [Related]
20. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]